This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Sanofi is here to support you and your patients.

Ask us your questions about our products, patient materials or organising a meeting.

There is an intense desire to participate in fasting during Ramadan, even among the people who could seek exemption1. Discover the ORION study and the 2021 IDF-DAR Practical guidance.


Download a summary of the ORION study. Real-world safety and effectiveness of Toujeo® in patients with Type 2 Diabetes who choose to fast during Ramadan.

Full Publication

Read the full publication of the ORION observational study in patients with Type 2 Diabetes who choose to fast during Ramadan.


Toujeo® is indicated as treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.  

Patient Website

Find resources and support for your patients on Toujeo®. Help patients understand the basics of living and staying well with diabetes and how to have a positive start and experience with the medication prescribed to them.

MAT-XU-2205631 (v6.0) Date of Preparation: October 2023